- ►annals.org MA Dimopoulos, H Kantarjian, E Estey, S O' … - Annals of internal medicine, 1993 - cat.inist.fr Treatment of Waldenstrom macroglobulinemia with 2-chlorodeoxyadenosine. MA
DIMOPOULOS, H KANTARJIAN, E ESTEY, S O'BRIEN, K DELASALLE ... Cited by 82 - Related articles - All 3 versions
- ►jcojournal.org [PDF] MA Dimopoulos, H Kantarjian, D Weber, S O' … - Journal of Clinical Oncology, 1994 - jcojournal.org Purpose: To assess the activity of 2-chlorodeoxyade- nosine (2CdA) as primary
therapy for patients with Wal- denstrim's macroglobulinemia. Patients and
Methods: 2CdA was given to 26 consec- utive, previously untreated and ... Cited by 97 - Related articles - BL Direct - All 6 versions
MA Dimopoulos, S O'brien, S Pierce, K … - The American journal of medicine, 1993 - cat.inist.fr Fludarabine therapy in Waldenström's macroglobulinemia. MA DIMOPOULOS,
S O'BRIEN, S PIERCE, K DELASALLE, B BARLOGIE, R ALEXANIAN ... Cited by 74 - Related articles - All 2 versions
ES Liu, C Burian, WE Miller, A Saven - British journal of haematology, 1998 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 44 - Related articles - BL Direct - All 5 versions
- ►bloodjournal.org [PDF] HM Kantarjian, R Alexanian, CA Koller, R … - Blood, 1990 - Am Soc Hematology . reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ... Cited by 64 - Related articles - All 3 versions
MA Dimopoulos, DM Weber, H Kantarjian, M … - Annals of Oncology, 1994 - Eur Soc Med Oncology Background: Fludarabine monophosphate and 2Chloro- deoxyadenosine are nucleoside
analogues with activity against Waldenstrom macroglobulinemia. However, it is
not clear whether prior exposure to one analogue precludes re- sponse to ... Cited by 34 - Related articles - BL Direct - All 3 versions
MT Petrucci, G Avvisati, M Tribalto, P … - Journal of internal medicine, 1989 - cat.inist.fr Waldenström's macroglobulinaemia: results of a combined oral treatment
in 34 newly diagnosed patients. MT PETRUCCI, G AVVISATI, M ... Cited by 37 - Related articles - All 3 versions
MA Dimopoulos, D Weber, KB Delasalle, M … - Annals of Oncology, 1995 - Eur Soc Med Oncology Background: Few effective treatments are available for pa- tients with
Waldenstrom's macroglobulinemia that is resistant to standard therapies. We
assessed the activity of 2-chloro- deoxyadenosine (2CdA) in patients with ... Cited by 50 - Related articles - BL Direct - All 3 versions
PL Zinzani, F Gherlinzoni, M Bendandi, A … - European journal of haematology, 1995 - interscience.wiley.com Abstract: Fludarabine (FLU) is a fluorinated purine analogue with a promising
antineoplastic activity in lymphoproliferative disorders. In this study, we
evaluated the efficacy of FLU in 12 previously treated (primary refractory ... Cited by 48 - Related articles - BL Direct - All 3 versions
DC Betticher, SF Hsu Schmitz, D Ratschiller, … - British journal of haematology, 1997 - interscience.wiley.com Clinical trials with intravenous cladribine infusions in pretreated patients
with Waldenström's macroglobulinaemia have shown a response rate of 40%. Our
pharmacokinetic studies revealed that the bioavailability of subcutaneous ... Cited by 44 - Related articles - BL Direct - All 4 versions
